GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Veerhealth Care Ltd

Veerhealth Care wins Rs. 5.50 Crore order from leading FMCG company

ORDERS ▲ Positive Development MEDIUM RISK
📅 Filed on BSE: 20 Mar 2026, 04:48 PM IST  ·  BSE ID: 83235236-1d5c-4ac7-b4ce-e6f7ebb0e8f1
View Original BSE Filing (PDF)
💡
In Simple Terms
The company just won a Rs. 5.50 Crore order from a major FMCG company to supply face care products within 45 days.
🤖 AI Summary
  • Order worth Rs. 5.50 Crore from leading FMCG company for face care product supply
  • Execution timeline 45 days; order equals 76% of Q3 FY26 revenue of Rs. 7.26 Crore
  • Buyer is part of 125-year-old business group in personal and household care segment
  • Order represents approximately 20% of expected FY 2025-26 total revenues
🔢 Key Numbers — exact figures from BSE filing, not rounded
Order Value
Rs. 5.50 Crore
Q3 FY26 Revenue from Operations
Rs. 7.26 Crore
Order as % of Q3 FY26 Revenue
76%
Order as % of Expected FY 2025-26 Revenue
20%
Execution Timeline
45 days
FY 2026-27 Revenue Guidance
Rs. 45-50 Crore
FY 2026-27 PAT Guidance
7-10%
🏢 How This Affects the Company
📈
Business Impact
Order adds Rs. 5.50 Crore revenue pipeline, representing material contribution to FY26 performance and validation from established FMCG buyer. Positions company for domestic FMCG market expansion.
💰
Financial Impact
Rs. 5.50 Crore order converts to revenue within 45 days, contributing approximately 20% of management's stated FY 2025-26 revenue guidance and supporting stated FY 2026-27 target of Rs. 45-50 Crore.
⚙️
Operational Impact
45-day execution timeline requires production scaling. Order demonstrates manufacturing capacity to serve large FMCG clients and validates US FDA plant clearance credibility.
⚠️
Risk Impact
Single large order from one buyer creates concentration risk. Execution within 45-day window introduces delivery performance risk. Ability to sustain this customer relationship will determine repeat order visibility.
👥 What This Means For Shareholders
✅
Action Required
No action required. Monitor Q4 FY26 results filing for revenue recognition and customer contract details.
👤
Who Is Affected
All equity shareholders benefit from validated order pipeline and revenue guidance support. Debt holders benefit from cash generation. Order concentration creates risk for all shareholders if customer relationship terminates.
🔍
Management Signal
Management signals confidence in manufacturing capability and product competitiveness by accepting 45-day delivery timeline from established FMCG buyer. FY 2026-27 guidance of Rs. 45-50 Crore revenue anchors growth expectations beyond this single order.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Q4 FY26 results filing — verify Rs. 5.50 Crore revenue recognition and gross margin realization
Customer concentration disclosure in annual report — confirm FMCG buyer identity and repeat order visibility
FY 2026-27 guidance tracking — monitor Rs. 45-50 Crore revenue target and order pipeline updates
MEDIUM RISK Single-order revenue concentration, 45-day execution timeline with no stated payment terms, and unconfirmed repeat business from major customer create short-term execution and long-term sustainability risks.
💡 Investor Takeaway
Veerhealth Care secured Rs. 5.50 Crore order from major FMCG company — 76% of Q3 FY26 revenue and 20% of FY26 guidance. Execution within 45 days. Buyer credibility and FDA clearance strengthen credibility, but single-customer concentration requires monitoring.
⚖️ Strengths & Concerns

✅ Positives

  • Order equals 76% of Q3 FY26 revenues, validating product quality and market acceptance with major FMCG buyer.
  • US FDA plant clearance positions company distinctively; buyer is 125-year-old established group in personal care segment.

⚠️ Concerns

  • Single order from one customer creates revenue concentration; no visibility on repeat order or long-term contract terms disclosed.
  • 45-day execution timeline with no detail on payment terms, working capital requirements, or customer retention commitment.
You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again — explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.